CBD Blocked Pain and Nerve Damage in Rat Osteoarthritis, Especially When Given Early

Osteoarthritis was induced in male Wistar rats by intra-articular injection of monoiodoacetate (MIA). Pain was assessed using in vivo electrophysiology (joint nerve firing), von Frey hair algesiometry (withdrawal threshold), and dynamic incapacitance (weight bearing). CBD was administered locally at doses of 100-300 micrograms. Inflammation was measured via blood flow and leukocyte trafficking. Nerve health was assessed by G-ratio analysis of myelination.

Osteoarthritis is the most common joint disease worldwide, and its pain component involves both inflammation and nerve damage. Current analgesics manage symptoms but do not address nerve degeneration. CBD's dual action in this model, reducing pain while also protecting nerves, suggests a mechanism that goes beyond simple symptom relief.

This study contributes to the growing preclinical evidence base for CBD in pain management. The finding that early intervention with CBD could prevent both pain development and nerve damage is particularly interesting, as it suggests a potential disease-modifying effect rather than just symptom management. However, the local (intra-articular) route of administration differs from how most people use CBD.

Animal study using direct injection into the joint, which does not represent oral or topical CBD use in humans. The MIA model of OA causes rapid, chemically-induced joint damage that differs from the slow progression of human OA. Only male rats were studied. The CBD doses used were relatively high for local administration.